Clinical Outcomes of Patients with Rheumatoid Arthritis Treated in a Disease Management Program: Real-World Results
Pedro Santos-Moreno,1 Paola Castillo,2 Laura Villareal,3 Carlos Pineda,4 Hugo Sandoval,5 Omaira Valencia2 1Scientific Direction, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., Colombia; 2Research Department, Biomab Center for Rheumatoid Arthritis, Bogotá, D.C., Colombia;...
Enregistré dans:
Auteurs principaux: | Santos-Moreno P, Castillo P, Villareal L, Pineda C, Sandoval H, Valencia O |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2020
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/08d06c424a0f45dfab111ad9edc9f3ff |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tofacitinib: Real-World Data and Treatment Persistence in Rheumatoid Arthritis
par: Bertoldi I, et autres
Publié: (2021) -
Clinical and serological characteristics of Ecuadorian patients with rheumatoid arthritis
par: Ríos C, et autres
Publié: (2017) -
The onset of rheumatoid arthritis following trauma
par: Brawer AE, et autres
Publié: (2016) -
Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
par: Mysler E, et autres
Publié: (2021) -
Risk Factors Associated with Methotrexate Intolerance in Rheumatoid Arthritis Patients
par: Almalag H, et autres
Publié: (2020)